These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 27028849

  • 1. Pulmonary vasculature in COPD: The silent component.
    Blanco I, Piccari L, Barberà JA.
    Respirology; 2016 Aug; 21(6):984-94. PubMed ID: 27028849
    [Abstract] [Full Text] [Related]

  • 2. Pulmonary vascular abnormalities in chronic obstructive pulmonary disease undergoing lung transplant.
    Peinado VI, Gómez FP, Barberà JA, Roman A, Angels Montero M, Ramírez J, Roca J, Rodriguez-Roisin R.
    J Heart Lung Transplant; 2013 Dec; 32(12):1262-9. PubMed ID: 24263025
    [Abstract] [Full Text] [Related]

  • 3. Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management.
    Barberà JA, Blanco I.
    Drugs; 2009 Jun 18; 69(9):1153-71. PubMed ID: 19537834
    [Abstract] [Full Text] [Related]

  • 4. Pulmonary hypertension in chronic obstructive pulmonary disease.
    Barberà JA, Peinado VI, Santos S.
    Eur Respir J; 2003 May 18; 21(5):892-905. PubMed ID: 12765440
    [Abstract] [Full Text] [Related]

  • 5. Pulmonary hypertension in COPD: pathophysiology and therapeutic targets.
    Zakynthinos E, Daniil Z, Papanikolaou J, Makris D.
    Curr Drug Targets; 2011 Apr 18; 12(4):501-13. PubMed ID: 21194405
    [Abstract] [Full Text] [Related]

  • 6. Pulmonary vascular involvement in COPD.
    Peinado VI, Pizarro S, Barberà JA.
    Chest; 2008 Oct 18; 134(4):808-814. PubMed ID: 18842913
    [Abstract] [Full Text] [Related]

  • 7. Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension.
    Wang L, Jin YZ, Zhao QH, Jiang R, Wu WH, Gong SG, He J, Liu JM, Jing ZC.
    Int J Chron Obstruct Pulmon Dis; 2017 Oct 18; 12():3353-3360. PubMed ID: 29200842
    [Abstract] [Full Text] [Related]

  • 8. Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension.
    Hajian B, De Backer J, Vos W, Van Holsbeke C, Ferreira F, Quinn DA, Hufkens A, Claes R, De Backer W.
    Int J Chron Obstruct Pulmon Dis; 2016 Oct 18; 11():1533-41. PubMed ID: 27462149
    [Abstract] [Full Text] [Related]

  • 9. Compartment-specific remodeling patterns in end-stage chronic obstructive pulmonary disease with and without severe pulmonary hypertension.
    Zeder K, Marsh LM, Avian A, Brcic L, Birnhuber A, Douschan P, Foris V, Sassmann T, Hoetzenecker K, Boehm PM, Kwapiszewska G, Olschewski A, Olschewski H, Kovacs G.
    J Heart Lung Transplant; 2024 Jul 18; 43(7):1090-1101. PubMed ID: 38382583
    [Abstract] [Full Text] [Related]

  • 10. [New pathophysiological concepts in pulmonary hypertension in COPD].
    Firă-Mladinescu O, Tudorache V, Mihăicuţă S, Cristescu A.
    Pneumologia; 2003 Jul 18; 52(3-4):188-92. PubMed ID: 18210732
    [Abstract] [Full Text] [Related]

  • 11. Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.
    Weitzenblum E, Chaouat A, Canuet M, Kessler R.
    Semin Respir Crit Care Med; 2009 Aug 18; 30(4):458-70. PubMed ID: 19634085
    [Abstract] [Full Text] [Related]

  • 12. Pulmonary hypertension in COPD: old and new concepts.
    Barberà JA, Peinado VI, Santos S.
    Monaldi Arch Chest Dis; 2000 Dec 18; 55(6):445-9. PubMed ID: 11272628
    [Abstract] [Full Text] [Related]

  • 13. Pulmonary hypertension in chronic lung diseases.
    Seeger W, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs S, Martinez FJ, Semigran MJ, Simonneau G, Wells AU, Vachiéry JL.
    J Am Coll Cardiol; 2013 Dec 24; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [Abstract] [Full Text] [Related]

  • 14. Reactive Oxygen Species in COPD-Related Vascular Remodeling.
    Zuo L, Chuang CC, Clark AD, Garrison DE, Kuhlman JL, Sypert DC.
    Adv Exp Med Biol; 2017 Dec 24; 967():399-411. PubMed ID: 29047102
    [Abstract] [Full Text] [Related]

  • 15. Computed tomographic measurement of airway remodeling and emphysema in advanced chronic obstructive pulmonary disease. Correlation with pulmonary hypertension.
    Dournes G, Laurent F, Coste F, Dromer C, Blanchard E, Picard F, Baldacci F, Montaudon M, Girodet PO, Marthan R, Berger P.
    Am J Respir Crit Care Med; 2015 Jan 01; 191(1):63-70. PubMed ID: 25393421
    [Abstract] [Full Text] [Related]

  • 16. The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations.
    Sakao S, Voelkel NF, Tatsumi K.
    Eur Respir Rev; 2014 Sep 01; 23(133):350-5. PubMed ID: 25176971
    [Abstract] [Full Text] [Related]

  • 17. Pulmonary hemodynamic profile in chronic obstructive pulmonary disease.
    Portillo K, Torralba Y, Blanco I, Burgos F, Rodriguez-Roisin R, Rios J, Roca J, Barberà JA.
    Int J Chron Obstruct Pulmon Dis; 2015 Sep 01; 10():1313-20. PubMed ID: 26203238
    [Abstract] [Full Text] [Related]

  • 18. Phenotypic assessment of pulmonary hypertension using high-resolution echocardiography is feasible in neonatal mice with experimental bronchopulmonary dysplasia and pulmonary hypertension: a step toward preventing chronic obstructive pulmonary disease.
    Reynolds CL, Zhang S, Shrestha AK, Barrios R, Shivanna B.
    Int J Chron Obstruct Pulmon Dis; 2016 Sep 01; 11():1597-605. PubMed ID: 27478373
    [Abstract] [Full Text] [Related]

  • 19. Pulmonary hypertension secondary to chronic obstructive pulmonary disease.
    Gologanu D, Stanescu C, Bogdan MA.
    Rom J Intern Med; 2012 Sep 01; 50(4):259-68. PubMed ID: 23610973
    [Abstract] [Full Text] [Related]

  • 20. Pulmonary hypertension in chronic obstructive pulmonary disease.
    Weitzenblum E, Chaouat A, Kessler R.
    Pneumonol Alergol Pol; 2013 Sep 01; 81(4):390-8. PubMed ID: 23744170
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.